Skip to main content
Biomind Labs logo

Biomind Labs — Investor Relations & Filings

Ticker · BMND LEI · 254900YBPPG0XSZOE887 NEO Professional, scientific and technical activities
Open in API
Filings indexed 196 across all filing types
Latest filing 2025-11-25 Regulatory Filings
Country CA Canada
Listing NEO BMND

About Biomind Labs

https://www.biomindlabs.com/

Biomind Labs is a biotechnology research and development company focused on creating novel pharmaceutical drugs for patients suffering from neurological and psychiatric disorders. The company employs an R&D acceleration platform to develop next-generation formulations, including those based on key endogenous substances. A core technological focus is the integration of nanotech delivery systems to target the underlying drivers of disease.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings Classification · 1% confidence The document is a Form 13-501F1, which is a regulatory filing used by reporting issuers in Alberta, Canada, to calculate and report their participation fees based on market capitalization. It is a specific regulatory form submitted to the Alberta Securities Commission. Since it does not fit into categories like financial reports, earnings releases, or shareholder communications, it falls under the general regulatory filings category.
2025-11-25 English
Decision Document / Order for Application - English.pdf
Regulatory Filings Classification · 1% confidence The document is a formal 'Revocation Order' issued by the Ontario Securities Commission regarding a 'failure-to-file cease trade order' (FFCTO). It details the regulatory status of Biomind Labs Inc., confirming that the company has fulfilled its outstanding continuous disclosure obligations and that the cease trade order is now revoked. This is a regulatory legal order issued by a securities commission, which falls under the 'Regulatory Filings' category as it does not fit into specific financial reporting or corporate action categories like 10-K, ER, or MANG.
2025-11-25 English
News release - English.pdf
Report Publication Announcement Classification · 1% confidence The document is a press release announcing the filing of various continuous disclosure documents (MD&A, financial statements) on SEDAR+ and the appointment of a new director. Per the 'Menu vs Meal' rule, this is an announcement of reports being filed rather than the reports themselves. Since it covers multiple types of filings (financials, governance, and management changes) and serves as a notification of publication, it is best classified as a Report Publication Announcement (RPA).
2025-11-18 English
52-109F2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 1% confidence The document is a 'Form 52-109F2', which is a standard Canadian regulatory filing for the 'Certification of Interim Filings'. It is a legal certification by the CEO regarding the accuracy and internal controls of the interim financial reports and MD&A. Since it is a regulatory certification document that does not fit into the specific categories of financial reports, management presentations, or announcements, it falls under the 'Regulatory Filings' (RNS) category as the appropriate fallback.
2025-11-18 English
52-109F2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 1% confidence The document is a Form 52-109F2, which is a standard Canadian regulatory filing for the 'Certification of Interim Filings'. It is signed by the CFO and confirms the review and fair presentation of interim financial reports and MD&A. Since it is a regulatory certification document rather than the financial report itself, and it does not fit into specific categories like 'Annual Report' or 'Earnings Release', it falls under the 'Regulatory Filings' category.
2025-11-18 English
Interim MD&A - English.pdf
Management Reports Classification · 1% confidence The document is explicitly titled 'Management's Discussion and Analysis' (MD&A) for the three and nine-month periods ended September 30, 2025. It provides a detailed narrative explanation of the company's business, financial outlook, and operational risks, which is the standard content for an MD&A report. It is not an earnings release (which is a summary) nor a full annual report (10-K), but rather the management commentary section that accompanies interim financial statements.
2025-11-18 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.